<p>HeLa cell viability after 24h incubation with doxorubicin, Dex-NPs, Dox-NPs and rDox-NPs.</p
<p>RAW264.7 and Hela were placed in the upper and lower chambers of Transwell plates, respectively. ...
<p>HeLa (A) or RKO (B) cells were treated with digoxin (green symbols) or 21-BD (red symbols) for 24...
<p>HT-29 cells were treated with increasing concentrations of oxaliplatin (1–100 μM) in the presence...
<p>The HepG2 (A) and A549 (B) cells were evaluated with a standard MTS assay after 48 h of further i...
<p>(A) Cell cycle analysis: the blue area represents the control cells, the red line indicates treat...
<p>(A) Cell viability assays following ONC201 treatment at indicated concentrations for 72 hours (n ...
Percent viable and apoptotic cells for DU145, DU145-TXR after DTX time course treatment.</p
<p><b>Copyright information:</b></p><p>Taken from "Role of the p53/p21 system in the response of hum...
<p>Three different treatment combinations were tested on SHEP NB cells, giving NVP-BEZ235 12 hrs pri...
<p>HepG2 (A, B) or Huh7 (C, D) human hepatoma cells were incubated with 1, 5 or 10 μM TR3, TR4 or TR...
<p>Cells were treated 5 µg/ml doxorubicin for 24 hrs. (A) Fluorescence intensity image; the contours...
HEK293, SK-BR-3, BT-20, HUVEC, PASMC and hiPS cardiomyocytes were treated with increasing amounts of...
<p>HepG2 cells were pretreated with 3 µmol/L tunicamycin for 8 hr, either in the absence or the pres...
(A) Neonatal rat cardiomyocytes were treated with indicated doses of Dox for 24h. Glucose regulated ...
<p>(a) Relative cell viability of LH86 (target cell line); (b) Relative cell viability of Hu1229 (hu...
<p>RAW264.7 and Hela were placed in the upper and lower chambers of Transwell plates, respectively. ...
<p>HeLa (A) or RKO (B) cells were treated with digoxin (green symbols) or 21-BD (red symbols) for 24...
<p>HT-29 cells were treated with increasing concentrations of oxaliplatin (1–100 μM) in the presence...
<p>The HepG2 (A) and A549 (B) cells were evaluated with a standard MTS assay after 48 h of further i...
<p>(A) Cell cycle analysis: the blue area represents the control cells, the red line indicates treat...
<p>(A) Cell viability assays following ONC201 treatment at indicated concentrations for 72 hours (n ...
Percent viable and apoptotic cells for DU145, DU145-TXR after DTX time course treatment.</p
<p><b>Copyright information:</b></p><p>Taken from "Role of the p53/p21 system in the response of hum...
<p>Three different treatment combinations were tested on SHEP NB cells, giving NVP-BEZ235 12 hrs pri...
<p>HepG2 (A, B) or Huh7 (C, D) human hepatoma cells were incubated with 1, 5 or 10 μM TR3, TR4 or TR...
<p>Cells were treated 5 µg/ml doxorubicin for 24 hrs. (A) Fluorescence intensity image; the contours...
HEK293, SK-BR-3, BT-20, HUVEC, PASMC and hiPS cardiomyocytes were treated with increasing amounts of...
<p>HepG2 cells were pretreated with 3 µmol/L tunicamycin for 8 hr, either in the absence or the pres...
(A) Neonatal rat cardiomyocytes were treated with indicated doses of Dox for 24h. Glucose regulated ...
<p>(a) Relative cell viability of LH86 (target cell line); (b) Relative cell viability of Hu1229 (hu...
<p>RAW264.7 and Hela were placed in the upper and lower chambers of Transwell plates, respectively. ...
<p>HeLa (A) or RKO (B) cells were treated with digoxin (green symbols) or 21-BD (red symbols) for 24...
<p>HT-29 cells were treated with increasing concentrations of oxaliplatin (1–100 μM) in the presence...